174 related articles for article (PubMed ID: 16831170)
21. Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma.
Furuya M; Nishiyama M; Kimura S; Suyama T; Naya Y; Ito H; Nikaido T; Ishikura H
J Pathol; 2004 May; 203(1):551-8. PubMed ID: 15095478
[TBL] [Abstract][Full Text] [Related]
22. [Cloning and identifying of renal cell carcinoma differentially expressed genes].
Zhang Q; Zhang Z; Xin D; Liang L; Na Y; Guo Y
Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):935-8. PubMed ID: 11832202
[TBL] [Abstract][Full Text] [Related]
23. Comparative transcriptional and functional profiling of clear cell and papillary renal cell carcinoma.
Diegmann J; Tomiuk S; Sanjmyatav J; Junker K; Hindermann W; von Eggeling F
Int J Mol Med; 2006 Sep; 18(3):395-403. PubMed ID: 16865223
[TBL] [Abstract][Full Text] [Related]
24. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
25. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
26. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
Christoph F; Hinz S; Kempkensteffen C; Schostak M; Schrader M; Miller K
J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
[TBL] [Abstract][Full Text] [Related]
27. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of activator protein-2 isoforms in renal cell carcinoma.
Oya M; Mikami S; Mizuno R; Miyajima A; Horiguchi Y; Nakashima J; Marumo K; Mukai M; Murai M
Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Suganuma N; Segade F; Matsuzu K; Bowden DW
BJU Int; 2007 May; 99(5):1143-9. PubMed ID: 17437443
[TBL] [Abstract][Full Text] [Related]
30. Novel blood biomarkers of human urinary bladder cancer.
Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760
[TBL] [Abstract][Full Text] [Related]
31. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
[TBL] [Abstract][Full Text] [Related]
32. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
Slabý O; Svoboda M; Michálek J; Vyzula R
Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
[TBL] [Abstract][Full Text] [Related]
33. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
34. Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma.
Sartini D; Muzzonigro G; Milanese G; Pierella F; Rossi V; Emanuelli M
J Urol; 2006 Nov; 176(5):2248-54. PubMed ID: 17070307
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling predicts survival in conventional renal cell carcinoma.
Zhao H; Ljungberg B; Grankvist K; Rasmuson T; Tibshirani R; Brooks JD
PLoS Med; 2006 Jan; 3(1):e13. PubMed ID: 16318415
[TBL] [Abstract][Full Text] [Related]
36. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
37. Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma.
Brito GC; Fachel AA; Vettore AL; Vignal GM; Gimba ER; Campos FS; Barcinski MA; Verjovski-Almeida S; Reis EM
Mol Carcinog; 2008 Oct; 47(10):757-67. PubMed ID: 18348187
[TBL] [Abstract][Full Text] [Related]
38. Interferon-alpha resistance associated genes in renal cell carcinoma identified by expression profiling.
Korkola JE; Kondagunta GV; Reuter VE; Motzer RJ; Chaganti RS
J Urol; 2007 Apr; 177(4):1264-8; discussion 1268. PubMed ID: 17382702
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
40. Retinal gene profiling in a hereditary rodent model of elevated intraocular pressure.
Naskar R; Thanos S
Mol Vis; 2006 Oct; 12():1199-210. PubMed ID: 17102796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
